Atrial Anomalies Predict Silent Atrial Fibrillation Detected by Implantable Cardiac Monitor in Cryptogenic Stroke
CRIPTO-FAST
Subtle Ultrasound Atrial Anomalies Predicts the Early Diagnosis of Silent Atrial Fibrillation Detected by Implantable Cardiac Monitor in Patients With Cryptogenic Stroke. A Randomized Trial
1 other identifier
interventional
100
1 country
1
Brief Summary
Cryptogenic stroke (CS) causes about 30% of admissions to a stroke unit. Silent paroxysmal atrial fibrillation (PAF) is believed to be the underlying cause of a significant proportion of patients. The use of implantable cardiac monitors (ICM) early after the CS has demonstrated benefits in the diagnostic yield, but the indication for ICM in the current guidelines remains unclear. Atrial contraction strain (ACS) evaluated by cardiac ultrasound could be of help to select the patients more prone to suffer from silent PAF. The purpose of this investigation is to conduct a randomized prospective unicentric study to evaluate the usefulness of ICM for early detection of silent PAF episodes in patients with CS. Clinical and ultrasound predictors of PAF occurrence (ACS) will be studied in order to define patients needing a closer follow-up.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2021
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2021
CompletedFirst Submitted
Initial submission to the registry
July 21, 2024
CompletedFirst Posted
Study publicly available on registry
August 7, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2024
CompletedAugust 7, 2024
August 1, 2024
3.7 years
July 21, 2024
August 2, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Detection atrial fibrilation at follow-up
defined by the presence of a confirmatory 12-leads ECG, or a registration lasting more than 30 seconds in, either the 72h-Holter-Monitoring, or in the ICM recording. In case of AF detection OAC was initiated immediately.
Up to 2 years follow-up (ICM and standard care practice)
Secondary Outcomes (5)
LA indexed volume
Before Day 3 since the Criptogenic Stroke
Maximum Systolic Global Longitudinal Strain (PALs)
Before Day 3 since the Criptogenic Stroke
Atrial Contraction Strain (PACs)
Before Day 3 since the Criptogenic Stroke
Atrial Ejection Fraction
Before Day 3 since the Criptogenic Stroke
stroke recurrences
Up to 2 years follow-up (ICM and standard care practice)
Study Arms (4)
Atrial cardiomyopathy by echocardiogram intervention
EXPERIMENTALPresence of Atrial cardiomyopathy is defined by echocardiogram if ANY of the following is present: 1. LA dilatation: indexed volumen \>32 ml/m2 2. PALS (Peak atrial longitudinal strain) \<21% 3. PACS ( Peak atrial contraction strain ) \<13% 4. Atrial ejection fraction \<55%
Atrial cardiomyopathy by echocardiogram standard practice
NO INTERVENTIONPresence of Atrial cardiomyopathy is defined by echocardiogram if ANY of the following is present: 1. LA dilatation: indexed volumen \>32 ml/m2 2. PALS (Peak atrial longitudinal strain) \<21% 3. PACS ( Peak atrial contraction strain ) \<13% 4. Atrial ejection fraction \<55%
Non atrial cardiomyopathy by echocardiogram intervention
EXPERIMENTALAbsence of atrial cardiomyopathy is defined by echocardiogram if none of the characteristics bellow were accomplished. 1. LA dilatation: indexed volumen \>32 ml/m2 2. PALS (Peak atrial longitudinal strain) \<21% 3. PACS ( Peak atrial contraction strain ) \<13% 4. Atrial ejection fraction \<55%
Non atrial cardiomyopathy by echocardiogram standard practice
NO INTERVENTIONAbsence of atrial cardiomyopathy defined by echocardiogram if none of the characteristics bellow were accomplished. 1. LA dilatation: indexed volumen \>32 ml/m2 2. PALS (Peak atrial longitudinal strain) \<21% 3. PACS ( Peak atrial contraction strain ) \<13% 4. Atrial ejection fraction \<55%
Interventions
ICM implant 3-4 days after the stroke and prior to discharge. All devices (Abbott Confirm or Jot) were implanted subcutaneously under local anaesthesia in the left chest region and programmed with an specific algorithm for AF detection set at 30 seconds for detection. All patients were included in remote monitoring system (Merlin), which was programmed to send alerts in case of registering episodes qualifying for AF detection, and a monthly routine registration. All ICM recordings were reviewed by a specialized cardiologist.
Eligibility Criteria
You may qualify if:
- Acute ischemic stroke or transient ischemic attack (TIA) from January 2022 to July 2023
- Age between 50 and 89 years;
- Undetermined origin at hospital admission according to the SSS-TOAST criteria (2):
- Absence of major structural heart disease by cardiac ultrasound (normal global and segmental left ventricle contraction, absence of valvular/rheumatic disease, absence of intracardiac shunts)
- Absence of AF during 48h ECG-monitoring
- Absence of major anomalies in the supra-aortic trunks ultrasound.
You may not qualify if:
- Patients with a history of hemorrhagic stroke;
- Presence with prior atrial fibrillation or atrial flutter;
- Permanent contraindication or indication for OAC for other reasons;
- Recent (\<1 month) major surgery or cardiac events;
- Presence of severe cardiac abnormalities;
- Patients with life expectancy \<1 year or severe stroke (modified Rankin Scale \> 4).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital del Mar
Barcelona, 08003, Spain
Related Publications (15)
Andrew NE, Thrift AG, Cadilhac DA. The prevalence, impact and economic implications of atrial fibrillation in stroke: what progress has been made? Neuroepidemiology. 2013;40(4):227-39. doi: 10.1159/000343667. Epub 2013 Jan 24.
PMID: 23364221BACKGROUNDSposato LA, Cipriano LE, Saposnik G, Ruiz Vargas E, Riccio PM, Hachinski V. Diagnosis of atrial fibrillation after stroke and transient ischaemic attack: a systematic review and meta-analysis. Lancet Neurol. 2015 Apr;14(4):377-87. doi: 10.1016/S1474-4422(15)70027-X. Epub 2015 Mar 4.
PMID: 25748102BACKGROUNDRubiera M, Aires A, Antonenko K, Lemeret S, Nolte CH, Putaala J, Schnabel RB, Tuladhar AM, Werring DJ, Zeraatkar D, Paciaroni M. European Stroke Organisation (ESO) guideline on screening for subclinical atrial fibrillation after stroke or transient ischaemic attack of undetermined origin. Eur Stroke J. 2022 Sep;7(3):VI. doi: 10.1177/23969873221099478. Epub 2022 Jun 3.
PMID: 36082257BACKGROUNDCuadrado-Godia E, Benito B, Ois A, Valles E, Rodriguez-Campello A, Giralt-Steinhauer E, Cabrera S, Alcalde O, Jimenez-Lopez J, Jimenez-Conde J, Marti-Almor J, Roquer J. Ultra-early continuous cardiac monitoring improves atrial fibrillation detection and prognosis of patients with cryptogenic stroke. Eur J Neurol. 2020 Feb;27(2):244-250. doi: 10.1111/ene.14061. Epub 2019 Sep 18.
PMID: 31424609BACKGROUNDKlijn CJ, Paciaroni M, Berge E, Korompoki E, Korv J, Lal A, Putaala J, Werring DJ. Antithrombotic treatment for secondary prevention of stroke and other thromboembolic events in patients with stroke or transient ischemic attack and non-valvular atrial fibrillation: A European Stroke Organisation guideline. Eur Stroke J. 2019 Sep;4(3):198-223. doi: 10.1177/2396987319841187. Epub 2019 Apr 9.
PMID: 31984228BACKGROUNDPagola J, Juega J, Francisco-Pascual J, Bustamante A, Penalba A, Pala E, Rodriguez M, De Lera-Alfonso M, Arenillas JF, Cabezas JA, Moniche F, de Torres R, Montaner J, Gonzalez-Alujas T, Alvarez-Sabin J, Molina CA; Crypto-AF study group. Predicting Atrial Fibrillation with High Risk of Embolization with Atrial Strain and NT-proBNP. Transl Stroke Res. 2021 Oct;12(5):735-741. doi: 10.1007/s12975-020-00873-2. Epub 2020 Nov 13.
PMID: 33184686BACKGROUNDAlbers GW, Bernstein RA, Brachmann J, Camm J, Easton JD, Fromm P, Goto S, Granger CB, Hohnloser SH, Hylek E, Jaffer AK, Krieger DW, Passman R, Pines JM, Reed SD, Rothwell PM, Kowey PR. Heart Rhythm Monitoring Strategies for Cryptogenic Stroke: 2015 Diagnostics and Monitoring Stroke Focus Group Report. J Am Heart Assoc. 2016 Mar 15;5(3):e002944. doi: 10.1161/JAHA.115.002944. No abstract available.
PMID: 27068633BACKGROUNDRubio Campal JM, Garcia Torres MA, Sanchez Borque P, Navas Vinagre I, Zamarbide Capdepon I, Miracle Blanco A, Bravo Calero L, Saez Pinel R, Tunon Fernandez J, Serratosa Fernandez JM. Detecting Atrial Fibrillation in Patients With an Embolic Stroke of Undetermined Source (from the DAF-ESUS registry). Am J Cardiol. 2020 Feb 1;125(3):409-414. doi: 10.1016/j.amjcard.2019.10.050. Epub 2019 Nov 6.
PMID: 31780074BACKGROUNDMarks D, Ho R, Then R, Weinstock JL, Teklemariam E, Kakadia B, Collins J, Andriulli J, Hunter K, Ortman M, Russo AM. Real-world experience with implantable loop recorder monitoring to detect subclinical atrial fibrillation in patients with cryptogenic stroke: The value of p wave dispersion in predicting arrhythmia occurrence. Int J Cardiol. 2021 Mar 15;327:86-92. doi: 10.1016/j.ijcard.2020.11.019. Epub 2020 Nov 10.
PMID: 33186666BACKGROUNDChorin E, Peterson C, Kogan E, Barbhaiya C, Aizer A, Holmes D, Bernstein S, Schole M, Duraiswami H, Spinelli M, Park D, Chinitz L, Jankelson L. Comparison of the Effect of Atrial Fibrillation Detection Algorithms in Patients With Cryptogenic Stroke Using Implantable Loop Recorders. Am J Cardiol. 2020 Aug 15;129:25-29. doi: 10.1016/j.amjcard.2020.05.027. Epub 2020 May 23.
PMID: 32600783BACKGROUNDMagnusson P, Lyren A, Mattsson G. Diagnostic yield of chest and thumb ECG after cryptogenic stroke, Transient ECG Assessment in Stroke Evaluation (TEASE): an observational trial. BMJ Open. 2020 Sep 24;10(9):e037573. doi: 10.1136/bmjopen-2020-037573.
PMID: 32973062BACKGROUNDLumikari TJ, Putaala J, Kerola A, Sibolt G, Pirinen J, Pakarinen S, Lehto M, Nieminen T. Continuous 4-week ECG monitoring with adhesive electrodes reveals AF in patients with recent embolic stroke of undetermined source. Ann Noninvasive Electrocardiol. 2019 Sep;24(5):e12649. doi: 10.1111/anec.12649. Epub 2019 May 2.
PMID: 31045315BACKGROUNDKalani R, Bernstein R, Passman R, Curran Y, Ruff I, Prabhakaran S. Factual Inaccuracies Contained in the Article Entitled "Low Yield of Mobile Cardiac Outpatient Telemetry after Cryptogenic Stroke in Patients with Extensive Cardiac Imaging". J Stroke Cerebrovasc Dis. 2017 Dec;26(12):3035. doi: 10.1016/j.jstrokecerebrovasdis.2017.09.018. Epub 2017 Oct 18. No abstract available.
PMID: 29054732BACKGROUNDZiegler PD, Rogers JD, Ferreira SW, Nichols AJ, Richards M, Koehler JL, Sarkar S. Long-term detection of atrial fibrillation with insertable cardiac monitors in a real-world cryptogenic stroke population. Int J Cardiol. 2017 Oct 1;244:175-179. doi: 10.1016/j.ijcard.2017.06.039. Epub 2017 Jun 10.
PMID: 28624331BACKGROUNDZiegler PD, Rogers JD, Ferreira SW, Nichols AJ, Sarkar S, Koehler JL, Warman EN, Richards M. Real-World Experience with Insertable Cardiac Monitors to Find Atrial Fibrillation in Cryptogenic Stroke. Cerebrovasc Dis. 2015;40(3-4):175-81. doi: 10.1159/000439063. Epub 2015 Aug 28.
PMID: 26314298BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ermengol Valles Gras, PhD
Hospital del Mar
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Head of arrhythmias
Study Record Dates
First Submitted
July 21, 2024
First Posted
August 7, 2024
Study Start
January 1, 2021
Primary Completion
September 1, 2024
Study Completion
December 1, 2024
Last Updated
August 7, 2024
Record last verified: 2024-08
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR
- Time Frame
- After the publication and during 10 years
- Access Criteria
- Upon reasonable request
All data from this study, including pseudoanonimized data from ultrasound exams and ECG signals from ICM will be available.